Unreliability of Depopulated Bovine Ureteric Xenograft for Infra Inguinal Bypass Surgery: Mid-term Results from Two Vascular Centres

V. Tolva, G. B. Bertoni, S. Trimarchi, V. Grassi, M. Fusari, V. Rampoldi

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: We report a two centre experience with a depopulated ureteric xenograft (SGVG 100 ®, CryoLife Inc., GA, USA) for femoropopliteal revascularization in 12 patients with chronic critical limb ischemia. Report: Between 7 days and 18 months after implantation, 10 of 12 patients (1 lost to follow-up) had the graft explanted due to aneurysmal enlargement. At 5 years, only one graft was still patent and showed moderate signs of enlargement. Conclusion: The SGVG 100 ® is not a safe conduit for femoropopliteal bypass surgery.

Original languageEnglish
Pages (from-to)214-216
Number of pages3
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume33
Issue number2
DOIs
Publication statusPublished - Feb 2007

Keywords

  • Bypass surgery
  • Critical limb ischemia
  • Graft
  • Infection
  • Xenograft

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Surgery

Fingerprint

Dive into the research topics of 'Unreliability of Depopulated Bovine Ureteric Xenograft for Infra Inguinal Bypass Surgery: Mid-term Results from Two Vascular Centres'. Together they form a unique fingerprint.

Cite this